Michael Saylor’s Bitcoin Gambit: The Prisoner’s Dilemma of Holding and Selling
Much has been written about Michael Saylor’s use of bonds to create a Ponzi-like mechanism for buying Bitcoin for $MSTR. Rather, I would like zoom out and examine the more […]
Super Micro Computer (SMCI): Navigating Turbulence Amid Strong Demand
Super Micro Computer, Inc. (SMCI) has been on a rollercoaster ride in recent months, with its stock price experiencing significant volatility due to concerns about potential fraud and delisting from […]
Navigating the Markets in Trump’s America: Strategic Investment Moves for 2025 and Beyond
As President Donald Trump returns to the White House, investors are presented with a unique set of opportunities and challenges. His administration’s policies are expected to emphasize deregulation, corporate tax cuts, domestic manufacturing, and a pro-crypto stance, all of which could have significant implications for various sectors of the economy. At GreenSight Capital, we’ve analyzed…
Humacyte (NASDAQ: HUMA): A Promising Biotech Investment Despite FDA Delays
Humacyte, Inc. (NASDAQ: HUMA) is a clinical-stage biotechnology company that has been making waves in the field of regenerative medicine. The company’s flagship product, the Acellular Tissue Engineered Vessel (ATEV), […]
Elevate Your Game
Join the GreenSight Newsletter for insightful market commentary and exclusive research delivered directly to your inbox